Is Indication-Specific Drug Pricing the Solution?
As rapidly as cancer treatments are advancing, so is pricing. To help find ways to reduce drug costs, payers must focus on exploring types of value-based payments. (more…)
Kellie and Jeremy talk Vertical Integration in PharmExec.com
As the US healthcare landscape continues to change at a rapid rate, Kellie Rademacher and Jeremy Schafer take a closer look at the emerging trend of vertical integration. (more…)
Drugmakers need to focus on how a drug improves total patient health
In an article in Managed Care, Jeremy Schafer discusses the findings from a recent breast cancer study reported in JAMA. (more…)
New PHE Study Determines Long-term Cancer Survivors Fare as Well or Better Than Everyone Else
Led by a team of PHE researchers, a new study appearing in the American Journal of Managed Carehas determined that long-term cancer survivors can expect health and quality of life on par with Americans of the same age and background. (more…)
PHE’s Shafrin and Linthicum Discuss Patient-Centered Formulary Challenges in Health Affairs
In a recent column in Health Affairs, Precision’s Jason Shafrin and Mark Linthicum address how value assessment frameworks are leading to more patient-centered formularies.
Maureen Hennessey and Elizabeth Oyekan Discuss the Importance of Motivational Interviewing
Following their presentation at AMCP 2018, Maureen and Elizabeth talked with Managed Healthcare Executive to discuss the importance of Motivational Interviewing and shared some of their tips for successfully conducting motivational interviews. (more…)
Dominic Galante featured in ISPOR’s Values & Outcomes Spotlight
Dominic Galante explains how a fragmented Health Technology Assessment landscape in the United States is one of many struggles medical devices face when determining healthcare value.
precisioneffect Acquires European Marketing Agency, Big Pink
Addition of London-based multichannel healthcare agency complements and strategically expands existing global expertise and capabilities
BOSTON, MA – April 24, 2018 – precisioneffect, the healthcare advertising agency dedicated to working with companies that seek to change the standard of care, today announced it is acquiring Big Pink, a leading European multichannel marketing healthcare agency recognized for providing strategically designed and creatively delivered campaigns to the pharmaceutical industry worldwide. The acquisition marks an important expansion of precisioneffect’s global footprint and employee base, and positions the company to provide its clients with additional value through enhanced services and expertise. (more…)
Precision Xtract Covers Economic Assessment of Novel Gene and Cellular Therapies in the Journal of Clinical Pathways
Phil Cyr and Larry Blandford offer their experience and insights on developing health economic models for gene and cellular therapies. (more…)
Precision for Value Strengthens and Expands Industry-Leading Payer Strategy Team
TAPPING FORMER PAYER DECISION MAKERS BOYCE, HONCZ AND OYEKAN
BRINGS UNRIVALED INSIGHTS TO CLIENTS
APRIL 18th, 2018 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in demonstrating the value and outcomes of innovative medical products, today announced significant additions to its Payer Strategy Team with the hiring of former payer executives Marylou Buyse, Joe Honcz, and Elizabeth Oyekan. (more…)